# Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery Disease

*PRI Rank #15 · Topics and Trends in Most Cited Atrial Fibrillation Management and Outcomes Papers, Class of 2026*

*Canonical URL: https://pri.pepkio.com/top-papers/atrial-fibrillation-management-and-outcomes/2026/rank-15*

| Field | Value |
| --- | --- |
| Rank | #15 |
| 18m citations | 74 |
| Journal | New England Journal of Medicine |
| Year | 2024 |
| DOI | 10.1056/nejmoa2407362 |
| Corresponding authors | Min Soo Cho |
| Institution | Asan Medical Center, South Korea |

**Ranking page:** [Topics and Trends in Most Cited Atrial Fibrillation Management and Outcomes Papers, Class of 2026](https://pri.pepkio.com/top-papers/atrial-fibrillation-management-and-outcomes/2026)

**Paper link:** [10.1056/nejmoa2407362](https://doi.org/10.1056/nejmoa2407362)

## Topics

Edoxaban monotherapy · Dual antithrombotic therapy · atrial fibrillation · Stable coronary artery disease · CHA2DS2-VASc score · Direct oral anticoagulants · Major bleeding · clinically relevant nonmajor bleeding · Myocardial infarction · Thromboembolic events · Unplanned urgent revascularization · Composite primary endpoint · Thromboembolic events · Antithrombotic therapy · EPIC-CAD trial

## Cite this ranking

```
Pepkio Research Index (PRI). Topics and Trends in Most Cited Atrial Fibrillation Management and Outcomes Papers, Class of 2026. https://pri.pepkio.com/top-papers/atrial-fibrillation-management-and-outcomes/2026. Accessed 2026-07-14.

Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459
```